Literature DB >> 14607560

Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles.

Madelon van Wely1, Lars G Westergaard, Patrick M M Bossuyt, Fulco van der Veen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14607560     DOI： 10.1016/s0015-0282(03)02190-3

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  2 in total

1.  In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review.

Authors:  Geoffrey H Trew; Adam P Brown; Samantha Gillard; Stuart Blackmore; Christine Clewlow; Paul O'Donohoe; Radoslaw Wasiak
Journal:  Reprod Biol Endocrinol       Date:  2010-11-08       Impact factor: 5.211

2.  Comparison of ovulation induction and pregnacy outcomes in IVF patients with normal ovarian reserve who underwent long protocol with recombinant-FSH and highly purified-hMG.

Authors:  Cem Celik; Kenan Sofuoğlu; Selçuk Selçuk; Mehmet Reşit Asoğlu; Remzi Abalı; Elçin Cetingöz; Bahar Baykal; Mehmet Uludoğan
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.